NightHawk Biosciences Inc (NHWK)

[dia76ca]

itsabouttime... Lots of news could come this year.

We should get top line results from the phase 2 NSCLC HS-110 plus low dose cyclophosphamide in June or July. Low dose CPA has been used as a priming dose in several recent CAR-T trials.

We should get the 2 year update on the phase 2 HS-410 + SOC trial in bladder cancer in the fall. Interim results show immune response effect not seen with SOC alone. Often SOC alone results fall off by as much as 40% in the second year.

We could get an update on the open label phase 2 HS-110 plus Opdivo NSCLC at any time. If it continues to turn 50-60% of cold tumours into hot tumours...it will be of great interest to international pharmas!

We could see several new drugs go into the clinic.
We could see the first ComPACT (gp96 + OX40) trial.
We could see the first PTX-25 trial(funded by Texas).
We could see some Zika preclinical results.

We could also receive partnering news at any time. We know that "an international pharmaceutical company" took part in the recent cash raise by the Shattuck Labs spinoff. The name of the company has not been revealed....but they are obviously interested. If there is partnering there could be a phase 3 by the end of this year or early next year. Or there could just be a buyout. There is plenty about Heat for Big Pharmas to like IMO!